Clinical risk factors for DN progression include age, BMI, smoking status, glycated haemoglobin (HbA1c), elevated systolic blood pressure, diabetic retinopathy, high-density lipoprotein, triglyceride, increased urinary albumin excretion and declining eGFR (17–19). The gene discussed is ALB; the disease is liver dysplastic nodule.